412 related articles for article (PubMed ID: 22161385)
1. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
2. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Cates CJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2008 Jul; (3):CD004106. PubMed ID: 18646100
[TBL] [Abstract][Full Text] [Related]
3. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD007694. PubMed ID: 20091646
[TBL] [Abstract][Full Text] [Related]
4. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
5. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Sao Paulo Med J; 2010; 128(5):310-1. PubMed ID: 21181075
[TBL] [Abstract][Full Text] [Related]
6. Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2003; (4):CD003794. PubMed ID: 14583994
[TBL] [Abstract][Full Text] [Related]
7. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
8. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
9. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
Aballéa S; Cure S; Vogelmeier C; Wirén A
Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
[TBL] [Abstract][Full Text] [Related]
10. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007085. PubMed ID: 19160317
[TBL] [Abstract][Full Text] [Related]
11. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
[TBL] [Abstract][Full Text] [Related]
12. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
[TBL] [Abstract][Full Text] [Related]
13. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Apr; (2):CD007313. PubMed ID: 19370682
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
15. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
[TBL] [Abstract][Full Text] [Related]
16. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
[TBL] [Abstract][Full Text] [Related]
17. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
[TBL] [Abstract][Full Text] [Related]
18. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2012 Mar; 3(3):CD007695. PubMed ID: 22419326
[TBL] [Abstract][Full Text] [Related]
19. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ; Jaeschke R
Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
[TBL] [Abstract][Full Text] [Related]
20. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]